New York State Teachers Retirement System Purchases 4,673 Shares of Sotera Health (NASDAQ:SHC)

New York State Teachers Retirement System raised its position in Sotera Health (NASDAQ:SHC) by 8.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,173 shares of the company’s stock after purchasing an additional 4,673 shares during the period. New York State Teachers Retirement System’s holdings in Sotera Health were worth $796,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Blue Trust Inc. increased its stake in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after purchasing an additional 1,140 shares in the last quarter. True Wealth Design LLC bought a new stake in shares of Sotera Health during the third quarter worth $32,000. GAMMA Investing LLC increased its position in shares of Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after acquiring an additional 1,121 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of Sotera Health during the third quarter worth $91,000. Finally, Oak Thistle LLC bought a new stake in shares of Sotera Health during the fourth quarter worth $222,000. Institutional investors own 91.03% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on SHC. Barclays lowered their price objective on shares of Sotera Health from $18.00 to $17.00 and set an “overweight” rating for the company in a research report on Tuesday, February 18th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective for the company. Citigroup increased their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.08.

Sotera Health Price Performance

Sotera Health stock opened at $13.52 on Monday. The company has a market cap of $3.83 billion, a P/E ratio of 54.08 and a beta of 1.91. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The company has a fifty day simple moving average of $13.45 and a 200 day simple moving average of $14.56. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.